Cleared Traditional

K933237 - MEDI-STIM, MODIFICATION

K933237 is an FDA 510(k) clearance for MEDI-STIM, manufactured by Mid-Canada Medical. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 441-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1994
Decision
441d
Days
Class 2
Risk

K933237 is an FDA 510(k) clearance for the MEDI-STIM, MODIFICATION. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Mid-Canada Medical (Mississauga, Ontario, CA). The FDA issued a Cleared decision on September 8, 1994 after a review of 441 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K933237

510(k) Number K933237 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 1993
Decision Date September 08, 1994
Days to Decision 441 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
292d slower than avg
Panel avg: 149d · This submission: 441d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K933237.
STERILE TREATMENT ELECTRODE
K941923 · Staodyne, Inc. · Jun 1995
TRANSAMERICAN CLASSIC TENS
K944280 · Transamerica Biomedical, Inc. · May 1995
GUARDIAN DISPOSABLE TENS AND TENS/NMES ELECTRODES
K945676 · Selectivemed Components, Inc. · Jan 1995
BIO SDP (AKA SATURN SD, GLC-III SD & STAT-SD)
K934051 · Skylark Device Co., Ltd. · Jul 1994
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR
K932897 · Nemectron GmbH · Jul 1994
STAT-TENS
K931079 · Skylark Device Co., Ltd. · Jun 1994